NL-OMON46165招募中不适用
Fungal infections as complication of monoclonal antibody therapy directed against IL-17 mediated inflammation: estimating incidence and severity and identifying influence of immunogenetics to establish a guideline for screening, prevention and treatment. - Fungal infections as complication of anti-Th17 mAB therapy.
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •* Diagnosis of psoriasis
- •* Age * 18 years
- •* Treatment with either a TNF-*-inhibitor for at least 1 year, ustekinumab for at least 1 year, secukinumab for at least 6 months, ixekizumab for at least 6 months or brodalumab for at least 6 months or planning to start treatment with an anti-Th17 mAb therapeutic agent
- •* Registration in the BioCAPTURE registry
排除标准
- •* Pregnancy
- •* Any active cancer treatment
研究者
相似试验
招募中
不适用
Incidence and outcome of invasive fungal infections in pediatric patients with hematological malignancies and/or undergoing allogeneic hematopoietic stem cell transplantation – a prospective analysis in three major pediatric cancer centers (IFI-PED Study)”Children with hematological malignancy (C91.0C92.0)/children undergoing hematopoietic stem cell transplantationproven, probable, and possible invasive fungal infection (B49)B49C92.0C91.0Unspecified mycosisAcute myeloblastic leukaemia [AML]Acute lymphoblastic leukaemia [ALL]DRKS00006341Pädiatrische Hämatologie und OnkologieKlinik für Kinder- und JugendmedizinJohann Wolfgang Goethe Universität500
已完成
4 期
King's invasive aspergillosis study II (KIASII)Specialty: Haematology, Primary sub-specialty: HaematologyUKCRC code/ Disease: Infection/ Other bacterial diseasesInfections and InfestationsInvasive fungal diseaseISRCTN11847553King's College Hospital NHS Foundation Trust120
进行中（未招募）
1 期
Incidence of Invasive Fungal Disease in Patients receiving Immunosuppressive Therapy, Intensive Chemotherapy or Reduced Intensity Haematopoietic Stem Cell Transplantation on Posaconazole tablet ProphylaxisAplastic Anaemia, Myelodysplastic syndromes, Acute Myeloid Leukaemia undergoing immunosuppression therapy, high dose chemotherapy or reduced intensity stem cell transplantationMedDRA version: 19.0Level: LLTClassification code 10038271Term: Refractory anaemia with excess blasts in transformationSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10059041Term: Allogeneic peripheral haematopoietic stem cell transplantSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.0Level: LLTClassification code 10067862Term: Allogeneic stem cell transplantationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.0Level: PTClassification code 10038270Term: Refractory anaemia with an excess of blastsSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: LLTClassification code 10010776Term: Constitutional aplastic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.0Level: LLTClassification code 10068063Term: Aplastic anaemia relapseSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.0Level: LLTClassification code 10036699Term: Primary idiopathic aplastic anaemiaSystem Organ Class: 10005329 - Blood and lymphatic system disordersMedDRA version: 19.0Level: PTClassification code 10000880Term: Acute myeloid leukaemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10001756Term: Allogenic bone marrow transplantation therapySystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 19.0Level: LLTClassification code 10000884Term: Acute myeloid leukaemia NOSSystem Organ Class: 10029104 -EUCTR2016-001223-31-GBKing's College Hospital NHS Foundation Trust150
招募中
不适用
Risk factors and antifungal susceptibility of non-albicans candida in patient with candidemiaAge more than 18 yearsCandidemiacandidemiarisk factorsdrug susceptibilityantifungalTCTR20190501003Faculty of Medicine Siriraj Hospital150
招募中
不适用
Impact of antifungal prophylaxis. A prospective, multicenter, observational study in India (MISFIC)CTRI/2014/04/004544MSD PHARMA200